Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Health Product InfoWatch: September 2022
- Health Product InfoWatch: October 2022
- Health Product InfoWatch: November 2022
- Health Product InfoWatch: December 2022
- Appearance by Minister Petitpas Taylor before the Senate Standing Committee on Official Languages (OLLO) on June 5, 2023
- Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08)
- Notice: Prescription Drug List (PDL): Multiple Additions (2020-12-21)
- Health Product InfoWatch: January 2022
- Health Product InfoWatch – February 2022
- Health Product InfoWatch – March 2022
- Health Product InfoWatch: April 2022
- Health Product InfoWatch : May 2022
- Health Product InfoWatch: June 2022
- Health Product InfoWatch – July 2022
- Health Product InfoWatch – August 2022
- Notice of Compliance with conditions (NOC/c)
- Notice of Compliance (NOC) Database
- Notice of Compliance Listings
- HUMA committee briefing binder: Appearance of Minister of Families, Children and Social Development – February 14, 2023
- Notice of compliance (NOCC) database Frequently Asked Questions
- Notice of Compliance (NOC) Data Extract
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Overview
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Documentation
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Reporting categories
- Rozlytrek - Notice of Compliance with Conditions - Qualifying Notice
- Summary: Guidance Document - Post-Notice of Compliance (NOC) Changes: Framework Document (Pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Summary: Guidance Document- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy
- Vitrakvi - Notice of Compliance with Conditions - Qualifying Notice
- Arzerra - Notice of Compliance with Conditions - Qualifying Notice
- Balversa - Notice of Compliance with Conditions - Qualifying Notice
- Blincyto - Notice of Compliance with Conditions - Qualifying Notice
- Notice: Prescription Drug List (PDL): Avilamycin
- Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)
- Notice: Prescription Drug List (PDL): Diclofenac
- Notice: Prescription Drug List (PDL): Esomeprazole
- Notice: Prescription Drug List (PDL): Omeprazole
- Notice: Prescription Drug List (PDL): Fluticasone propionate
- Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials
- Notice: Prescription Drug List (PDL): Hydrocortisone
- Notice: Prescription Drug List (PDL): Hyoscine butylbromide
- Notice: Prescription Drug List (PDL): Minoxidil
- Notice: Prescription Drug List (PDL): Naloxone
- Notice: Prescription Drug List (PDL): Naproxen
- Notice: Prescription Drug List (PDL): Nicotine Qualifier Clarification
- Notice: Prescription Drug List (PDL): Polymyxin B
- Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
- Notice: Prescription Drug List (PDL): Triamcinolone acetonide
- Notice: Prescription Drug List (PDL): Vitamin D
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)